Stocks to sell

Workhorse (NASDAQ:WKHS) is a stock with a Beta (5Y Monthly) of 2.73 according to Yahoo! Finance. This means that based on the latest regression statistical data, WKHS stock is to move significantly more compared to the Beta of 1.0 for the S&P 500 or any other widely used stock market index. Source: Shutterstock If you like

The U.S. public and the market are belatedly realizing that the Delta variant of the coronavirus is not very dangerous, especially to those who are vaccinated and won’t stay in the U.S. for many months. Consequently, now is not a good time to buy highly valued stocks that thrive when consumers stay at home more.

This is certainly an odd economy. On one hand, the delta variant is a dark shadow over how long economic expansion lasts. On the other, the economy is booming and oil stocks have gone from zeros to heroes in the past year. The S&P Global Oil Index, which measures the performance of 120 of the

Right now everyone loves Square (NASDAQ:SQ) stock. Source: Jonathan Weiss / Shutterstock.com The company only came public in 2015, at a market cap of $2.9 billion. Today that number is right around $124 billion. At its current value Square is the third most valuable payment outfit, behind only MasterCard (NYSE:MA) and Visa (NYSE:V). But it

If you think Carnival (NYSE:CCL) and CCL stock is a good bet at almost $24, you might want to think again. Covid-19 is still very much still an “unwanted passenger” on its cruise ships. As a result, a resumption to pre-pandemic cruising — as well as improvements in the CCL stock price — seem like they’re

How far can a small medical devices company take a celebrity endorsement? The shares of veterinary diagnostics company Zomedica (NYSEAMERICAN:ZOM) surged after an endorsement from Tiger King celebrity Carole Baskin. In response, meme traders bid ZOM stock up sharply. Since the short interest in ZOM stock is high, the news created a dramatic short squeeze. Source:

Clover Health (NASDAQ:CLOV) has been one of the year’s biggest disappointments. The so-called King of SPACs (special purpose acquisition companies), Chamath Palihapitiya, took the health insurer public via one of his Social Capital Hedosophia SPACs. CLOV stock shares almost immediately tumbled after short sellers revealed that it had failed to disclose a government investigation into

Outlier Covid-19 vaccine play Ocugen (NASDAQ:OCGN) stock has been on a negative run in the past three months, losing about 17% of its value. Source: Shutterstock The company failed to gain an emergency use authorization (EUA) from the FDA for Covaxin, the Indian variant of the coronavirus vaccine. Moreover, its partner firm Bharat Biotech is

DiDi Global (NYSE:DIDI) could easily fall quite significantly to the value of just its non-China operations, plus its net cash (as long as that cash is not in China). This is because Chinese regulators have placed the company under dire restrictions. If that happens, I estimate that DIDI stock would be worth no more than

This is my first time writing about Novavax (NASDAQ:NVAX) and the more I learn about the company, I can’t help but think about Inception, the Leonardo DiCaprio movie about dreams within dreams. A lot of the discussion around Novavax’s Covid-19 vaccine feels like living in that film’s impossible dream worlds. People buying NVAX stock are believing

GameStop (NYSE:GME) remains one of the year’s most remarkable stock market stories. GME stock enjoyed not one but two historic short squeezes, leading to windfall profits for longs and incredible pain for skeptics such as Melvin Capital. Source: rblfmr / Shutterstock.com However, the fun may be winding down for GameStop. Shares have been sliding for

Warren Buffett once recommended that investors should be “greedy when others are fearful.”  Currently, there’s plenty of fear surrounding Chinese ride-hailing giant DiDi Global (NYSE:DIDI). Yet, this doesn’t mean it’s time to load up on shares DIDI stock. Source: Piotr Swat / Shutterstock.com Some folks have advised avoiding certain Chinese stocks due to the regulatory risks

Cassava Sciences (NASDAQ:SAVA) is a biotech company with an important goal: fighting Alzheimer’s disease. It has several treatments in development, but is SAVA stock worth adding to your portfolio? Source: Shutterstock Obviously, I want this company to succeed; I witnessed a family friend’s battle with Alzheimer’s disease, and I would love for Cassava to succeed

AT&T (NYSE:T) announced on May 17 that it would spin-off its WarnerMedia subsidiary and merge it with Discovery Communications (NASDAQ:DISCA, NASDAQ:DISCB, NASDAQ:DISCK) to create another massive media conglomerate. T stock has lost 13% of its value in the three months since.  Source: Shutterstock In 2021, AT&T’s stock has traded below $30 for all but a

Stock market gauges such as the S&P 500 index and Nasdaq 100 index continue to sit at or near all-time highs. While leading stocks continue to perform admirably, many companies have had a difficult summer. Small-cap firms, special purpose acquisition companies (SPACs), and unprofitable tech companies have seen their shares dive. If the corrections spread,

A spate of positive developments may be helping to keep AMC Entertainment (NYSE:AMC) stock steady. But should investors take this as a sign that it’s wise to buy in now, ahead of this “meme stock” favorite of the Reddit trading community surging higher once again? Source: viewimage / Shutterstock.com Not so fast. Its recent resiliency

Duolingo (NASDAQ:DUOL) reported excellent Q2 earnings on Aug. 11, essentially riding a wave of growth in language learning. The company just went public on July 26, raising about $406.2 million at $102 per share, according to its prospectus. (This was on top of the $114.6 million it already held, giving it a total of $520.8

Private company space wars seemed like science fiction just 10 or 20 years ago, but are now coming to fruition as multiple competitors gear up for the new race for space dominance. Jeff Bezos’s Blue Origin and Elon Musk’s SpaceX are among the leaders in the field. But one of the early innovators in this

Value investors are at a loss to explain the performance of Alibaba (NYSE:BABA) stock. Holding BABA stock in the hopes that the shares can return to their 52-week high may prove to be unprofitable. Source: BigTunaOnline / Shutterstock.com That’s because China’s government is introducing stricter regulations in many sectors. So despite paying a $2.75 billion

Although I’m a car enthusiast, I’m not in love with Nio (NYSE:NIO) stock. In fact, I’ve repeatedly suggested that investors avoid it in the past. Source: xiaorui / Shutterstock.com In 2020 I wrote the article “Nio Stock Has Skyrocketed in 2020, But High Risks Remain” using the Nasdaq Dozen method to analyze the company, I focused